Skip to main content
Medicine logoLink to Medicine
. 2021 Jan 29;100(4):e24582. doi: 10.1097/MD.0000000000024582

Effectiveness of dose-escalated topiramate monotherapy and add-on therapy in neurosurgery-related epilepsy: A prospective study: Erratum

PMCID: PMC7850737  PMID: 33530286

In the article, “Effectiveness of dose-escalated topiramate monotherapy and add-on therapy in neurosurgery-related epilepsy: A prospective study”,[1] which appears in Volume 99, Issue 52, Dr. Cheng-Chia Tsai has been added to the article.

Footnotes

How to cite this article: Liu YT, Chen GT, Huang YC. Effectiveness of dose-escalated topiramate monotherapy and add-on therapy in neurosurgery-related epilepsy: A prospective study. Medicine. 2021;100:4(e24582).

Reference

  • [1].Liu YT, Chen GT, Huang YC. Effectiveness of dose-escalated topiramate monotherapy and add-on therapy in neurosurgery-related epilepsy: A prospective study. Medicine. 2020. 99:e23771. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Medicine are provided here courtesy of Wolters Kluwer Health

RESOURCES